[Indolent non-Hodgkin's lymphoma].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000145:classification* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology
Indolente Non-Hodgkin-Lymphome.